The Binding Site

The annual American Society of Hematology (ASH) conference is the largest hematology conference in the world, with the 66th ASH conference being the biggest one to date. #ASH24 emphasised the significance of how early detection and accurate measurement of biomarkers can improve the survival and quality of life for patients with monoclonal gammopathies. We are committed to advancing diagnostic technologies to support this vital work. Discover more insights from ASH here: http://spr.ly/6044IVA3a #ASH24 #Hematology #MultipleMyeloma

Monoclonal gammopathy of undetermined significance (MGUS) can lead to complications such as bone fractures or kidney problems. Awareness of the clinical significance of MGUS and regular monitoring of patients is essential for effective patient management. Learn more about MGUS and its clinical significance: http://spr.ly/6042IYOYG

In a Swedish multicentric study by Veskovski et al. (2024), experts in haematology highlight the critical impact of serum free light chain analysis methods on myeloma diagnosis. Learn how Freelite ® assays can improve patient outcomes through these case studies: http://spr.ly/6048IcFyo

Monoclonal gammopathy of undetermined significance (MGUS) may not require treatment. However, it is important to be aware of its potential to progress to malignancies such as Multiple Myeloma or to develop comorbidities like renal insufficiency. Learn more about MGUS and its clinical significance: http://spr.ly/6044Ij3jn

Freelite® assays play a pivotal role in accurate diagnosis, treatment monitoring, and disease management to provide a better patient outcome. Read these patient cases which reinforce why Freelite assays have been trusted by the medical community worldwide for over 20 years. http://spr.ly/6049Iujq1

Did you know? Elevated CSF protein can be observed in many central nervous system (CNS) disorders. Find out more about the Optilite® Low Level Total Protein assay for urine and CSF total protein analysis: http://spr.ly/6041xYdyH

Monoclonal gammopathy of undetermined significance (MGUS) is often asymptomatic but can be a precursor to more serious conditions like Multiple Myeloma. Regular check-ups including blood tests are essential for those patients with MGUS. Discover how regular monitoring helps improve patient outcomes: http://spr.ly/6040xm96C

Today marks #WorldCancerDay, a timely reminder about the importance of early diagnosis in improving outcomes for all types of cancer. According to guidelines, the recommended tests for suspected monoclonal gammopathy include serum free light chains (sFLC) and serum protein electrophoresis (SPE), along with either upfront or reflex serum immunofixation electrophoresis (sIFE) testing. Take a look at our video to understand the importance of early diagnosis in #MultipleMyeloma, a malignant monoclonal gammopathy.

Veskovski et al. (2024) highlights several patient cases in which the choice of serum free light chain assay significantly impacted the patients’ lives. For over 20 years, Freelite® tests have been the trusted serum free light chain assay within the global medical and scientific community. Learn more about how Freelite assays transformed patient journeys and improved patient’s lives: http://spr.ly/6180xb1Jg

Did you know? Elevated urine total protein can be seen in many kidney related disorders - including chronic kidney disease and acute kidney injury. Find out more about the Optilite® Low Level Total Protein assay for urine and CSF total protein analysis http://spr.ly/6048xYkQA